Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

From the Editors

TOP - August 2014, Vol 7, No 3 - From the Editors

In this month’s issue of The Oncology Pharmacist (TOP), we present the fourth and final article in our series on oncology pharmacy safety. Christine Roussel, PharmD, BCOP, and Thomas H. Connor, PhD, discuss hazardous drug assessment, use of antineoplastic drugs in nononcology settings, oral chemotherapy, decontamination/cleaning, state legislative activities, and the new update to USP Chapter 800. One of the most interesting developments relates to actions taking place at the state level. The authors note, “The promulgation of new legislation related to safe handling of hazardous drugs by several states has forever changed the climate in which safe handling guidelines have been perceived.”

Please participate in our reader poll (see below), which ties into the issue of oncology pharmacy safety. We ask if you’ve collaborated with colleagues in developing safety protocols for the handling of potentially hazardous drugs. Roussel and Connor point out that “The growing use of hazardous drugs in nononcology practices and the increased utilization of oral hazardous drugs require the scope of safe handling practices to extend beyond traditional settings.” Please visit our website, www.TheOncologyPharmacist.com, and let us know if you have helped educate staff in other healthcare settings about potentially hazardous drugs.

When you visit the TOP website to participate in the poll, please take the time to give us your feedback about what you see in print and online. We want to hear from you!

Related Items
From The Editors: May 2022
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2022 Vol 15, No 3 published on May 6, 2022 in From the Editors
From The Editors March 2022
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in From the Editors
From The Editors
TOP - January 2022 Vol 15, No 1 – Online Only published on January 20, 2022 in From the Editors
From The Editors: November 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - November 2021 Vol 14, No 7 published on November 10, 2021 in From the Editors
From The Editors: October 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - October 2021 Vol 14, No 6 | Biosimilars published on November 5, 2021 in From the Editors, Biosimilars
From The Editors September 2021
Patrick J. Medina, PharmD, BCOP
TOP - September 2021 Vol 14, No 5 published on September 7, 2021 in From the Editors
From The Editors July 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - July 2021 Vol 14, No 4 published on July 20, 2021 in From the Editors
From The Editors May 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2021 Vol 14, No 3 published on May 14, 2021 in From the Editors
From The Editors March 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - March 2021 Vol 14, No 2 published on March 11, 2021 in From the Editors
From The Editors January 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - January 2021 Vol 14, No 1 published on February 9, 2021 in From the Editors
Last modified: July 22, 2021